» Articles » PMID: 30459166

Perspective on Prostate Cancer Screening

Overview
Journal Clin Chem
Specialty Biochemistry
Date 2018 Nov 22
PMID 30459166
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

The roles of proteases in prostate cancer.

Koistinen H, Kovanen R, Hollenberg M, Dufour A, Radisky E, Stenman U IUBMB Life. 2023; 75(6):493-513.

PMID: 36598826 PMC: 10159896. DOI: 10.1002/iub.2700.


Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction.

Ferraro S, Bussetti M, Bassani N, Rossi R, Incarbone G, Bianchi F Cancers (Basel). 2021; 13(14).

PMID: 34298597 PMC: 8305281. DOI: 10.3390/cancers13143381.

References
1.
Loeb S, Lilja H, Vickers A . Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer. Curr Opin Urol. 2016; 26(5):459-65. PMC: 5035435. DOI: 10.1097/MOU.0000000000000316. View

2.
Carlsson S, Vickers A, Roobol M, Eastham J, Scardino P, Lilja H . Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review. J Clin Oncol. 2012; 30(21):2581-4. PMC: 3413273. DOI: 10.1200/JCO.2011.40.4327. View

3.
Fleshner K, Carlsson S, Roobol M . The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA. Nat Rev Urol. 2016; 14(1):26-37. PMC: 5341610. DOI: 10.1038/nrurol.2016.251. View

4.
Vickers A, Eastham J, Scardino P, Lilja H . The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. Urology. 2016; 91:12-8. PMC: 4842100. DOI: 10.1016/j.urology.2015.12.054. View

5.
C Grossman D, Curry S, Owens D, Bibbins-Domingo K, Caughey A, Davidson K . Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018; 319(18):1901-1913. DOI: 10.1001/jama.2018.3710. View